Comparison 6. Failure to remission (16‐24 weeks).
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Citalopram versus other SSRIs | 1 | Odds Ratio (M‐H, Random, 95% CI) | Subtotals only | |
1.1 Versus Escitalopram | 1 | 357 | Odds Ratio (M‐H, Random, 95% CI) | 1.17 [0.74, 1.84] |
2 Citalopram versus SNRIs | 1 | Odds Ratio (M‐H, Random, 95% CI) | Subtotals only | |
2.1 Versus Venlafaxine XR | 1 | 151 | Odds Ratio (M‐H, Random, 95% CI) | 0.77 [0.35, 1.70] |
3 Citalopram versus other conventional ADs | 1 | Odds Ratio (M‐H, Random, 95% CI) | Subtotals only | |
3.1 versus Reboxetine | 1 | 357 | Odds Ratio (M‐H, Random, 95% CI) | 0.43 [0.28, 0.65] |